Notices
Revised NIH Parental Leave Policy for Ruth L. Kirschstein National Research Service Awards
(NOT-OD-16-105) National Institutes of Health
Revised: Notice of Reissuance of Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral MD/PhD or Other Dual-Doctoral Degree Fellowship (Parent F30)
(NOT-OD-16-107) National Institutes of Health
Findings of Research Misconduct
(NOT-OD-16-111) National Institutes of Health
Findings of Research Misconduct
(NOT-OD-16-112) National Institutes of Health
Findings of Research Misconduct
(NOT-OD-16-113) National Institutes of Health
Request for Information (RFI): Availability of Existing Longitudinal Cohort Studies with Physiologic Datasets and Stored Biospecimens for Use in Linked Cohort Designs
(NOT-AG-16-020) National Institute on Aging
Notice of Change to Eligibility in PAR-15-331 “Advanced Development of Informatics Technologies for Cancer Research and Management (U24)”
(NOT-CA-16-044) National Cancer Institute
Notice of Change to Eligibility in PAR-15-333 “Sustained Support for Informatics Resources for Cancer Research and Management (U24)”
(NOT-CA-16-045) National Cancer Institute
Notice of NIDCD’s Withdrawal from Participation in PA-16-310 “Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33)”
(NOT-DC-16-004) National Institute on Deafness and Other Communication Disorders
Notice of NEI Participation in PA-16-307 “Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32)”
(NOT-EY-16-003) National Eye Institute
Notice of NEI Participation in PA-16-306 “Ruth L. Kirschstein National Research Service Award (NRSA) Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)”
(NOT-EY-16-004) National Eye Institute
Notice of NEI Participation in PA-16-309 “Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31)”
(NOT-EY-16-005) National Eye Institute
Notice of NEI Participation in PA-16-308 “Ruth L. Kirschstein National Research Service Award Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31 – Diversity)”
(NOT-EY-16-006) National Eye Institute
Notice of NEI Participation in PA-16-305 “Ruth L. Kirschstein National Research Service Award (NRSA) Fellowship for Students at Institutions With NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)”
(NOT-EY-16-007) National Eye Institute
Notice of Research Strategy Page Limit for PAR-14-023 “Pre-application for a Biomedical Technology Research Resource (X02)”
(NOT-GM-16-110) National Institute of General Medical Sciences
Request for Information: Call for Nominations for NICHD’s Best Pharmaceuticals for Children Act Priorities in Pediatric Therapeutics 2017
(NOT-HD-16-011) Eunice Kennedy Shriver National Institute of Child Health and Human Development
Notice of NICHD Participation in PA-16-307 “Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32)”
(NOT-HD-16-012) Eunice Kennedy Shriver National Institute of Child Health and Human Development
Notice of NICHD Participation in PA-16-308 “Ruth L. Kirschstein National Research Service Award Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31 – Diversity)”
(NOT-HD-16-013) Eunice Kennedy Shriver National Institute of Child Health and Human Development
Notice of NICHD Participation in PA-16-309 “Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31)”
(NOT-HD-16-014) Eunice Kennedy Shriver National Institute of Child Health and Human Development
Clarification of NIH Policy on Post-Submission Application Materials for PAR-16-106 “Rapid Assessment of Zika Virus (ZIKV) Complications (R21)”
(NOT-HD-16-015) Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Eye Institute
National Heart, Lung, and Blood Institute
National Institute of Biomedical Imaging and Bioengineering
National Institute of Dental and Craniofacial Research
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
New NHLBI Policy: Investigator-Initiated Multi-Site Clinical Trials
(NOT-HL-16-321) National Heart, Lung, and Blood Institute
NHLBI Announces Interest in Administrative Supplements to Enhance HIV-related Heart, Lung, Blood, and Sleep Research
(NOT-HL-16-329) National Heart, Lung, and Blood Institute
Notice of Correction Regarding Eligibility of Foreign Components for PAR-16-301 “Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24)”
(NOT-HL-16-330) National Heart, Lung, and Blood Institute
Notice of Participation of NINDS in PAR-16-245 “Neural Regulation of Cancer (R01)”
(NOT-NS-16-031) National Institute of Neurological Disorders and Stroke
Notice of Participation of NINDS in PAR-16-246 “Neural Regulation of Cancer (R21)”
(NOT-NS-16-032) National Institute of Neurological Disorders and Stroke
Requests for Applications
Limited Competition: NIDCR Supplements to NCATS CTSA Programs for Scholars Pursing Dental, Oral and Craniofacial Clinical and Translational Research Career Development (Admin Supp)
(RFA-DE-17-008) National Institute of Dental and Craniofacial Research
Application Receipt Date(s): November 1, 2016, by 5:00 PM local time of applicant organization.
Neurocognitive Effects of Glycemic Dysregulation in Type 1 Diabetes (DP3)
(RFA-DK-16-007) National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): November 14, 2016, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Limited Competition for the Continuation of the Collaborative Islet Transplantation Registry (UC4)
(RFA-DK-16-503) National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): November 21, 2016, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Bold New Bioengineering Methods and Approaches for Heart, Lung, Blood and Sleep Disorders and Diseases (R21)
(RFA-HL-17-015) National Heart, Lung, and Blood Institute
Application Receipt Date(s): October 13, 2016; January 10, 2017; May 10, 2017; October 13, 2017; January 10, 2018; May 10, 2018; October 10, 2018; January 10, 2019; May 10, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Planning Grant for NINDS Morris K. Udall Parkinson’s Disease Research Center Without Walls (R34)
(RFA-NS-16-024) National Institute of Neurological Disorders and StrokeApplication Receipt Date(s): August 30, 2016, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Program Announcements
Collaborative Activities to Expedite Environmental Health Science Research, Translation, and Community Engagement Across EHS Core Centers (Admin Supp)
(PA-16-327)
National Institute of Environmental Health Sciences
Application Receipt/Submission Date(s): July 22, 2016 by 5:00 PM local time of applicant organization.
Limited Competition: Administrative Supplements to Enhance Network Capacity: Collaborative Opportunities for the CTSA Program (Admin Supp)
(PA-16-328)
National Center for Advancing Translational Sciences
Application Receipt/Submission Date(s): July 15, 2016; November 1, 2016; March 1, 2017; July 1, 2017; November 1, 2017; March 1, 2018; July 1, 2018; November 1, 2018; March 1, 2019 by 5:00 PM local time of applicant organization.
Nutrigenetics and Nutrigenomics Approaches for Nutrition Research (R01)
(PA-16-332)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Science of Behavior Change: Use-inspired Basic Research to Optimize Behavior Change Interventions and Outcomes (Admin Supp)
(PA-16-334)
NIH Roadmap Initiatives
Application Receipt/Submission Date(s): November 10, 2016, by 5:00 PM local time of applicant organization.
NHLBI Pilot Program to Provide Regulatory Support to SBIR/STTR Awardees Developing Medical Devices (Diagnostics and Therapeutics) (Admin Supp)
(PA-16-335)
National Heart, Lung, and Blood Institute
Application Receipt/Submission Date(s): August 15, 2016
Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R24)
(PAR-16-322)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Advancing Basic Behavioral and Social Research on Resilience: An Integrative Science Approach (UG3/UH3)
(PAR-16-326)
Office of Behavioral and Social Science Research
National Center for Complementary and Integrative Health
National Cancer Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Drug Abuse
National Institute of Environmental Health Sciences
National Institute of General Medical Sciences
National Institute of Mental Health
Application Receipt/Submission Date(s): December 1, 2016, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54)
(PAR-16-329)
National Institute of Neurological Disorders and Stroke
Application Receipt/Submission Date(s): September 13, 2016; September 12, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Countermeasures Against Chemical Threats (CounterACT): Identification of Therapeutic Lead Compounds (U01)
(PAR-16-330)
National Institute of Neurological Disorders and Stroke
Application Receipt/Submission Date(s): September 13, 2016; September 12, 2017; September 11, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01)
(PAR-16-331)
National Institute of Neurological Disorders and Stroke
Application Receipt/Submission Date(s): September 13, 2016; September 12, 2017; September 11, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Metabolic Contributions to the Neurocognitive Complications of Diabetes: Ancillary Studies (R01)
(PAR-16-333)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21)
(PAR-16-336)
National Cancer Institute
Application Receipt/Submission Date(s): Standard dates apply), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R03)
(PAR-16-337)
National Cancer Institute
Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01)
(PAR-16-338)
National Cancer Institute
Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
NIH Funding Opportunities now available in RSS (Really Simple News Syndication) format – see http://grants.nih.gov/grants/guide/rss_info.htm for details.
This weekly list can be found at: http://grants.nih.gov/grants/guide/WeeklyIndex.cfm?WeekEnding=06-17-2016
